Clinical Trials · NCT05230589

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice

Name: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ASemaglutide

Phase: N/A
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 194
Start date: Apr 2022
Locations: 2 sites, Saudi Arabia
Primary endpoint: Change in Glycated haemoglobin (HbA1c )

View Semaglutide compound reference